© Drug Hunter Inc. 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > WF-47-JS03
<< Back to February
RET kinase inhibitor
orally efficacious in XG but narrow TI
from data mining of internal matter and opt.
ACS Med. Chem. Lett. Feb. 12, 2020
Novartis (GNF), San Diego, CA
(Novartis (GNF) oral in vivo RET kinase inhibitor)
Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.